How to Screen for Anxiety-Depression Comorbidity in Clinical Practice
How should clinicians routinely assess for comorbid depressive and anxiety disorders when a patient presents with either syndrome?
Patients presenting with depression or anxiety often have the other disorder as well, and missing that comorbidity can underestimate severity and chronicity. In this NESDA cohort, comorbidity was common enough that the authors concluded both disorder groups should be assessed routinely regardless of the primary reason for consultation.
-
Assess both diagnostic domains at intake
Do not limit the evaluation to the apparent primary complaint. When a patient presents with a depressive disorder, assess for anxiety disorders as well, and when a patient presents with an anxiety disorder, assess for depressive disorders. This bidirectional assessment is supported by the high current comorbidity rates in the cohort: 67% of those with a depressive disorder had a current anxiety disorder, and 63% of those with a current anxiety disorder had a current depressive disorder.
-
Use a structured DSM-based diagnostic assessment
Establish diagnoses using DSM-IV-TR criteria with a structured interview approach rather than relying on the presenting symptom cluster alone. In the study, depressive disorders included major depressive disorder and dysthymia, and anxiety disorders included social phobia, panic disorder, agoraphobia, and generalized anxiety disorder. The article used hierarchy-free diagnoses to examine comorbidity thoroughly.
-
Pay particular attention to high-comorbidity disorder pairings
Be especially alert for mixed presentations in dysthymia and generalized anxiety disorder. The study found higher anxiety comorbidity in dysthymia than in major depressive disorder, and depressive comorbidity was highest in generalized anxiety disorder while lowest in agoraphobia alone. Social phobia and panic disorder were the most common anxiety comorbidities in depressive disorders, occurring in 41% and 42% of cases, respectively.
-
Characterize whether the patient has a higher-burden comorbid profile
If both anxiety and depressive disorders are present, evaluate clinical features linked to comorbidity rather than treating the second diagnosis as incidental. In the final multivariable model, comorbidity was associated with more childhood trauma, higher neuroticism, earlier age at onset of the first disorder, longer duration of depressive and/or anxiety symptoms, and higher symptom severity. These findings identify comorbid patients as a clinically distinct, higher-severity group.
-
Ask about age at onset and symptom duration
Clarify when the first disorder began and how persistent depressive and/or anxiety symptoms have been over time. In this study, early onset was defined as first onset before age 21 years, and longer symptom duration over the preceding 4 years was associated with comorbidity. Earlier onset and longer duration help distinguish patients more likely to have the comorbid pattern.
-
Reconstruct temporal sequence when both disorders are present
For patients with both anxiety and depressive disorders, determine whether anxiety began first, depression began first, or both began at the same age. The study found that anxiety preceded depression in 57% of comorbid cases, simultaneous onset occurred in 25%, and depression preceded anxiety in 18%. Social phobia especially often preceded depressive disorders, whereas generalized anxiety disorder most often had simultaneous onset with depression.
-
Interpret comorbidity as a marker of greater clinical burden
When anxiety-depression comorbidity is identified, recognize it as more than diagnostic overlap. The article concludes that comorbid patients had higher severity and longer duration of symptoms and may require a different or more intensive treatment approach. At minimum, the presence of comorbidity should change the clinician's assessment of illness burden and prognosis.
Clinical Considerations
- The study was cross-sectional, so the observed associations with comorbidity cannot be interpreted as causal.
- Age at onset was collected retrospectively, so temporal sequencing findings are subject to recall bias.
- Only selected anxiety disorders were assessed; obsessive-compulsive disorder and posttraumatic stress disorder were not included.
- Generalized anxiety disorder comorbidity rates were influenced by the study's use of hierarchy-free diagnoses and may have been lower if DSM hierarchy rules had been applied.
Bottom Line
Routinely assess both anxiety disorders and depressive disorders in every patient with either presentation, because comorbidity is common and marks a more severe, chronic clinical profile.
